1,1'-(4,4'-(Disulfanediylbis(methylene))bis(thiazole-4,2-diyl))diguanidine

Catalog No. :
ACLGVD780
CAS No. :
129083-44-9
Molecular Formula :
C10H14N8S4
Molecular Weight :
374.55

IUPAC Name:1,1'-(disulfanediylbis(1-methylene-1H-1l4-thiazole-4,2-diyl))diguanidine

1,1'-(4,4'-(Disulfanediylbis(methylene))bis(thiazole-4,2-diyl))diguanidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$2057.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1,1'-(4,4'-(Disulfanediylbis(methylene))bis(thiazole-4,2-diyl))diguanidine
IUPAC Name1,1'-(disulfanediylbis(1-methylene-1H-1l4-thiazole-4,2-diyl))diguanidine
Molecular FormulaC10H14N8S4
Molecular Weight374.55
SMILESC=S1C(NC(N)=N)=NC(SSC2=CS(C(NC(N)=N)=N2)=C)=C1
InChI KeyUDPYMFXUBRDIAY-UHFFFAOYSA-N
SynonymBis[(2-guanidino-4-thiazolyl)methyl]disulfide;Bis[(2-guanidino-4-thiazolyl)Methyl]disulfide (FaMotidine IMpurity);Famotidine Related Compound E (25 mg) (2,2'-[4,4'-disulfanediylbis(methylene)bis(thiazole-4,2-diyl)]diguanidine);N,N'''-[Dithiobis(Methylene-4,2-thiazolediyl)]bisguanidine;Bis[(2-guanidino-4-thiazolyl)Methyl]disulfide (85%) (FaMotidine IMpurity);2-[4-[[[2-(diaminomethylideneamino)-1,3-thiazol-4-yl]methyldisulfanyl]methyl]-1,3-thiazol-2-yl]guanidine;2,2'-[Disulfanediylbis-(methylenethiazole-4,2-diyl)]diguanidine;Famotidine USP Related Compound E
CAS No.129083-44-9

Synthetic Route by SureRoute

1. ACLGVD780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLGVD780 route product structure diagram
    ACLGVD780129083-44-9
Inquiry

2. ACLGVD780 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLGVD780 route product structure diagram
    ACLGVD780129083-44-9
Inquiry

Comments (0)